A fintech dashboard can celebrate completed applications while hiding the people who abandoned an identity check, misunderstood a fee or could not reach support. Consumer Duty makes that gap commercially important. The FCA expects firms to assess, test and evidence the outcomes customers actually receive, not merely record clicks or approve a board paper. For a product team, the challenge is practical: connect one customer need to one journey, price, communication, support route and outcome measure without slowing every experiment to a halt. The first purchasable decision is a bounded customer-journey outcome audit that follows one product from entry point to use, support and exit. This reading shows how a fintech or regulatory specialist can sell that audit, distinguish behavioural metrics from outcome evidence, redesign testing governance and build recurring assurance around product releases. It does not promise FCA acceptance, good outcomes for every customer, conversion growth or freedom from remediation.
What does Consumer Duty require a fintech to evidence?
Consumer Duty requires a firm to act to deliver good outcomes for retail customers, apply the cross-cutting rules and assess the products-and-services, price-and-value, consumer-understanding and consumer-support outcomes. The evidence must show what customers experience and what the firm changes when results are poor.
The FCA’s FG22/5 guidance makes outcome monitoring central. A product owner therefore needs more than policy compliance: a defined customer cohort, intended outcome, credible measures, thresholds, investigation owner and remediation route. The relevant perimeter follows regulated products and the firm’s material influence across manufacturers, distributors and outsourced journeys.
- 1Need and target market
- 2Entry, eligibility and choice
- 3Price, explanation and consent
- 4Use, support and foreseeable friction
- 5Exit, complaint and observed outcome
Why can a healthy conversion rate conceal foreseeable harm?
Conversion measures whether a customer completed a commercial step; it does not show whether the product met a need, the price represented fair value, the explanation was understood or support remained usable. A high-performing funnel can therefore coexist with poor or uneven customer outcomes.
Look for differences between cohorts, not only portfolio averages. Repeated retries, rapid cancellation, dormant balances, avoidable complaints, failed support contacts and unexplained drop-off can reveal friction. None proves harm alone. Together with customer research and case review, they tell the firm where to investigate.
- Conversion and activation
- Successful use and task completion
- Understanding and informed choice
- Support accessibility and resolution
- Complaints, exits and remediation
What should the first paid Consumer Duty purchase deliver?
The first purchase should be a fixed-scope audit of one product, customer cohort and digital journey. It should end with an outcome map, evidence gaps, risky design choices, prioritised tests, accountable owners and a decision to retain, redesign, investigate or stop the journey.
This is easier to approve than a firm-wide transformation because the evidence room is bounded. The specialist samples screens, pricing, disclosures, experiment logs, complaints, support contacts and outcome data. Legal interpretation, vulnerability data and individual remediation remain with authorised owners. The audit is valuable even when it concludes that the journey is adequately controlled.
Which evidence belongs in a customer-journey outcome map?
The map should connect target customer, need, product design, price, communication, behavioural choice, support path, intended outcome, observed signal and accountable owner. It must also record data limitations so silence is never misread as proof that customers received a good outcome.
| Evidence | Question it answers | Typical owner |
|---|---|---|
| Target-market and product record | Who should receive the product? | Product governance |
| Screens, prompts and experiments | What choice architecture did they see? | Product and growth |
| Price and benefit analysis | What value was intended? | Commercial/product |
| Cohort outcomes and case samples | What happened in practice? | Data/compliance |
| Support and complaint trail | Could customers obtain help? | Operations |
How should digital experiments be governed without freezing growth?
A fintech should classify experiments by potential customer impact, define prohibited manipulations, pre-agree outcome measures and require stronger approval where price, eligibility, vulnerability or exit is affected. Low-risk presentation tests can move quickly; material journey changes need evidence before and after release.
A small release record can capture hypothesis, cohort, intended commercial result, customer-outcome risk, measures, owner, stop condition and review date. This turns Consumer Duty into better experimentation discipline rather than a blanket veto. The fastest product team is the one that knows which changes need escalation.
Which customers disappear inside portfolio averages?
Customers in vulnerable circumstances, people using assistive technology, customers with limited digital confidence and those encountering financial difficulty can receive materially different outcomes. Monitoring should compare relevant cohorts while collecting only justified data and avoiding assumptions based on protected or sensitive characteristics.
The FCA’s published good and poor practice emphasises vulnerable customers, digital design, understanding and support. Use accessible research, journey testing, complaint narratives and carefully governed proxy signals. When data is incomplete, the correct state is “unknown — investigate”, not “no issue”.
- id6a76376911a53f0001fa32c2
- chartTypebar
- isModelledDatatrue
- rawtype: cohort-outcome-matrix title: Test whether averages hide a weaker customer experience axes: x: Journey stage y: Customer cohort cells: - Understanding - Task completion - Support resolution - Exit friction
- axes
- cellsUnderstanding · Task completion · Support resolution · Exit friction
What recurring service follows the first outcome audit?
A defensible recurring service reviews material releases, refreshes outcome measures, samples customer cases, tracks remediation and prepares evidence for product and board governance. It earns renewal by improving the decision system around change, not by repeating the same annual Consumer Duty presentation.
Cadence should follow release risk and product events. A fast-moving app may need monthly sampling and release gates; a stable product may need event-led reviews and quarterly governance. The contract must specify access to product, data, compliance and support owners because no external specialist can evidence outcomes from dashboards alone.
Which buying events reveal an urgent outcome-evidence gap?
A new product, pricing change, embedded-distribution partner, complaint pattern, board challenge, FCA information request or major funnel redesign creates a credible buying window. Outreach should name the operational decision and evidence required, not announce that the prospect is breaching Consumer Duty.
Search can capture named outcome problems; specialist partners can refer distribution-chain issues; selected outbound can target observable product changes. The qualification call should ask which journey changed, which customers are affected, what evidence exists and who can authorise remediation.
- Product or price launch
- New embedded partner
- Material complaint pattern
- Board or regulator challenge
- Major journey redesign
When is a Consumer Duty acquisition campaign ready?
Launch when the specialist can define one in-scope product journey, access outcome evidence safely, separate advisory work from regulated decisions and deliver a bounded audit with named owners. The fintech partner must provide product, compliance, data, support and executive access for the offer to remain credible.
The FCA’s Consumer Duty resources, FG22/5 guidance and published reviews bound the claims. No campaign should invent customer outcomes or imply regulator approval. Test one buyer segment and one journey problem before expanding; learning comes from qualified decisions, not from undifferentiated lead volume.
- 1Qualify the product and cohort
- 2Audit evidence and design
- 3Decide and remediate
- 4Monitor releases and outcomes
- 5Re-open when signals change
Could GetFishNet build a similar acquisition system for your fintech offer?
GetFishNet can test whether your expertise, target market, first paid audit and operating capacity form a credible acquisition opportunity. The free eligibility test identifies current acquisition pain points and possible development synergies; it does not promise campaign acceptance, customers, revenue or regulatory outcomes.
The useful starting point is one product, one buyer and one costly uncertainty. If the evidence and delivery capacity are present, we can design a tailored multichannel route around that decision and measure whether the market responds before scaling.
The eligibility report dates and quantifies it, then tests whether it deserves action.
Reading the diagram. A disease contact only progresses after proof of origin, qualification of the relationship and control of the product concerned.
Text alternative. Telephone, prescriber or incoming request follow different proofs; missing consent causes documented exit.
How can the testing cycle reach a stable operating rhythm?
Relative benchmarks: D00 sets the rules of origin and termination of contact, D14 closes the preparation, W03 to W06 tests the scripts, consents, relationships of more than thirty-six months and ceilings per product, W07 to W08 arbitrator, then M03 stabilizes documented paths. Variances are recorded before any budget extension.
Gantt chart for the testing cycle — NON-EXHAUSTIVE DEMONSTRATION
Reading the diagram. The foundation secures the right to contact; exploration then measures the quality of requests before any channel stabilization.
Textual alternative. D00 sets consent, D14 audits scripts, W03–W06 tests provenance, W07–W08 cuts discrepancies, M03 maintains compliance.
What financial potential does the model make visible?
Model: 132 qualified conversations, 44 reviews and 26 new customers. Weighted average: 1 527 CHF; monthly total: 39 700 CHF. The projection concerns acquisitions agreed and allocated, without using the ceilings as margin or portfolio value. No national denominator is applied.
Breakdown of acquisitions — NON-EXHAUSTIVE DEMONSTRATION
The chart counts customers, not percentage points.
Reading the diagram. 26 acquisitions represent subscriptions preceded by a controlled origin and relationship; the size of a share does not prejudge either the documentary quality or the maintained value.
Text alternative. The circle distributes customers obtained after verifiable consent, never people simply called. Total: 26 customers, reread with the value specific to each channel.
How do customers, average monthly revenue, and recurring revenue correlate by channel?
| Channel explored | Customers | Average monthly revenue per customer | Monthly Recurring Channel Revenue |
|---|---|---|---|
| Natural and paid referencing | 4 | 1 300 CHF | 5 200 CHF |
| Telephone outreach | 3 | 1 600 CHF | 4 800 CHF |
| Voicemails | 2 | 900 CHF | 1 800 CHF |
| Email Campaigns | 4 | 1 200 CHF | 4 800 CHF |
| Social networks | 3 | 1 400 CHF | 4 200 CHF |
| Partners and prescribers | 3 | 2 000 CHF | 6 000 CHF |
| Events and webinars | 2 | 1 700 CHF | 3 400 CHF |
| Advertising retargeting | 1 | 1 100 CHF | 1 100 CHF |
| Strategic accounts and outbound outreach | 2 | 2 300 CHF | 4 600 CHF |
| Content and press relations | 2 | 1 900 CHF | 3 800 CHF |
| Total / weighted average | 26 | 1 527 CHF | 39 700 CHF |
The value is read again with the product, the applicable ceiling and the cost of controlling the provenance. The product customers × average income totals 39 700 CHF without promising performance.
Monthly recurring revenue by channel — NON-EXHAUSTIVE DEMONSTRATION
Reading the diagram. Compliant disease contacts, their converted volumes and the corresponding monthly income recompose 39 700 CHF without a value outside the table.
Alternative text. Each height associates an authorized channel, actual assigned customers, and the value specific to their product. Their addition exactly equals monthly 39 700 CHF.
How should acquisition cost be assessed before recurring revenue is scaled?
Arbitration adds proof of consent, script control, relationship data, call supervision and refusal handling and reports the charge to assigned customers. It compares legal origin, product concerned, ceiling, full cost, expected termination and service capacity then reduces any channel that weakens the proof.
Funnel to Retained Monthly Recurring Revenue — NON-EXHAUSTIVE DEMONSTRATION
Reading the diagram. disease contacts whose origin is demonstrated produce raw 39 700 CHF, then 34 142 CHF after maintaining at 86 %.
Text alternative. 132 conversations become 44 journals and 26 clients for disease contacts whose provenance is demonstrated. 39 700 CHF weighted to 86 % gives 34 142 CHF.
Financial limit. The 70 francs and the sixteen bonuses limit the remuneration; they give neither margin, nor number of contracts, nor maintenance. The 34 142 CHF remains a hypothesis, without reference value or forecast.
Which sources and related readings deepen this analysis?
Text references: Federal Office of Public Health, decision and rules applicable to intermediaries; monitoring activity report. The federal office describes ceilings and outreach, while consent and history remain evidence specific to the file. The addresses remain in the internal source register. Each topic retains a clear documentary boundary.
The ISA 2024 processes the status. The ICA 2022 processes the contract trace. The nLPD 2023 shows another prequalification of the contact and data.
CORRELATED READINGS — DYNAMIC MODULE
The thematic map will link rules 2024 of health insurance intermediaries to ISA for status, ICA for contract and nLPD for legality of contact data. The links remain governed without implying equivalence.
- See the insurance & brokerage market
- Explore all market readings
- Test the eligibility of your own window
The September deadline has passed; each origin of contact must always be able to be explained The report isolates the proof and the next action without reopening the 2024 rules of health insurance intermediaries.
The topic is broken down into entities, attributes, evidence, channels, costs and decision points. Institutions are cited in the text; no external resource interrupts the reading path.